T1	Participants 29 66	in people at high cardiovascular risk
T2	Participants 479 560	in 9297 participants, including 3577 with diabetes and 1956 with microalbuminuria
T3	Participants 591 659	7674 participants with albuminuria data at baseline and at follow-up
T4	Participants 1745 1782	in nondiabetic and in diabetic people
